Rothschild Investment LLC Amphastar Pharmaceuticals, Inc. Transaction History
Rothschild Investment LLC
- $1.53 Trillion
- Q3 2024
A detailed history of Rothschild Investment LLC transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Rothschild Investment LLC holds 35 shares of AMPH stock, worth $1,272. This represents 0.0% of its overall portfolio holdings.
Number of Shares
35
Previous 15
133.33%
Holding current value
$1,272
Previous $600,000
183.17%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding AMPH
# of Institutions
286Shares Held
34.9MCall Options Held
74.3KPut Options Held
22.3K-
Black Rock Inc. New York, NY5.94MShares$216 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.71MShares$98.6 Million0.0% of portfolio
-
Td Asset Management Inc2.14MShares$77.6 Million0.1% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA1.95MShares$70.8 Million0.22% of portfolio
-
Neuberger Berman Group LLC New York, NY1.62MShares$58.7 Million0.06% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.78B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...